Health Economic Comparisonof Retrievable Self-expanding Full-covered Film Metal Stent and Endoscopic Dilation for Benign Anastomotic Stenosis after Esophagectomy of Esophageal Cancer: A Randomized Controlled Trial

Author:

Tao Zhang1,Liu Jie1,Pu Wenfeng1,Ren Ninchuan1,Feng Shenggang1,Zhang Yan1,Zhang Lisha1,Li Feng1,He Qingli1,Lin Fengying1,Du Zhonghan1,Hu Xiaosan1,Li Baohua2,Zhang Guihua3,Long Sizhe4,Li Ying5,Zhang Bing5

Affiliation:

1. Nanchong Central Hospital, North Sichuan Medical College

2. People’s Hospital of Yilong County

3. People’s Hospital of Yinsan County

4. Langzhong People’s Hospital

5. People’s Hospital of Nanbu County

Abstract

Abstract Background: Endoscopic dilation (ED) is common and effective for improving strictures in patients with benign esophageal anastomotic stenosis (BEAS) after esophagectomy. A retrievable self-expanding metal stent has also been proven effective in treating strictures. However, evaluations comparing health economics of stent placement and ED for BEAS are lack. Methods: In this prospective, randomized, controlled, multicenter study, BEAS patients between October 2020 and October 2021 at six centers were included. Patients were randomized into stent replacement (SR) or water balloon dilation (WBD) groups, and re-treatment interval times, body mass index (BMI) changes, dysphagia score, quality of life (QOL), treatment fees/times, total cost, daily cost, restenosis, and adverse effects assessed. Mann-Whitney U test was used for continuous variable analysis and Kaplan-Meier to calculate cumulative percentage and effective rate; significance was set at P<0.05. Results: Re-treatment interventions were more frequent in the WBD group (3 vs. 1.2, p<0.05) and re-treatment interval times longer (60-days vs. 7-days, p<0.05). Patient compliance was lower in the WBD group (p<0.001), while treatment cost was higher in SR patients (5001 vs. 1812 yuan, p <0.001). Daily treatment cost was lower in SR patients (78.57 vs 86.29 yuan, p<0.05). QOL (97 vs. 86, p<0.05), changes in posttreatment BMI (0 vs -0.72, p<0.05), and posttreatment dysphagia score (1 vs. 2, p<0.05) were higher in SR patients. There were three adverse events, two stent migrations, and one patient died following ED. Conclusions: SR patients had higher QOL due to longer retreatment intervals, fewer endoscopic interventions, and lower daily treatment costs. Trial registration: The study was registered in the Chinese Clinical Trial Registry, number ChiCTR2000037864.

Publisher

Research Square Platform LLC

Reference41 articles.

1. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors;Dustin J;Clin J Gastroentrol,2020

2. Global incidence of oesophageal cancer by histological subtype in 2012;Arnold M;Gut,2015

3. Population attributable risks of esophageal and gastric cancers;Engel LS;J Natl Cancer Inst,2003

4. International Agency for Research on Cancer (2011-11–28).

5. Early esophageal cancer screening in China;Gao Q-Y;Best Pract Res Clin Gastroenterol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3